HMGB1 promotes cellular chemokine synthesis and potentiates mesenchymal stromal cell migration via Rap1 activation

Lin,Feng; Xue,Deting; Xie,Tao; Pan,Zhijun

doi:10.3892/mmr.2016.5398

HMGB1 promotes cellular chemokine synthesis and potentiates mesenchymal stromal cell migration via Rap1 activation

Authors:
- Feng Lin
- Deting Xue
- Tao Xie
- Zhijun Pan
View Affiliations

Affiliations: Department of Orthopedics, The First People’s Hospital of Xiaoshan, Hangzhou, Zhejiang 311200, P.R. China, Department of Orthopedics, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310009, P.R. China
Published online on: June 13, 2016 https://doi.org/10.3892/mmr.2016.5398
Pages: 1283-1289

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The migration of mesenchymal stem cells (MSCs) and osteogenic differentiation occupy an important role in fracture healing. High mobility group box 1 (HMGB1), a widely distributed inflammatory factor in fractures, has been confirmed to act as a chemoattractant to MSCs. To investigate the effect of HMGB1 on MSC migration and the underlying mechanism, the synthesis of MSC chemokines, and the consequent activation of signaling pathways following HMGB1 stimulation, were evaluated. A Quantibody® array was performed to determine which chemokines were secreted from MSCs with or without treatment with HMGB1. The results indicated differential chemokine synthesis by MSCs following treatment with HMGB1, including that of CCL4 and CCL13. In addition, the Ras‑associated protein‑1 (Rap1) signaling pathway was markedly activated in the HMGB1‑treated groups, suggesting that HMGB1 may enhance the migrational ability of MSCs via Rap1 activation. Furthermore, HMGB1 was able to promote the secretion of various chemokines derived from MSCs, which would, in turn, increase the mobility of MSCs. Taken together, these results provide a mechanistic basis for developing novel approaches to promote fracture healing.

View Figures

View References

1	Naglova H and Bucova M: HMGB1 and its physiological and pathological roles. Bratisl Lek Listy. 113:163–171. 2012.PubMed/NCBI
2	Meng E, Guo Z, Wang H, Jin J, Wang J, Wang H, Wu C and Wang L: High mobility group box 1 protein inhibits the proliferation of human mesenchymal stem cells and promotes their migration and differentiation along osteoblastic pathway. Stem Cells Dev. 17:805–813. 2008. View Article : Google Scholar : PubMed/NCBI
3	Charoonpatrapong K, Shah R, Robling AG, Alvarez M, Clapp DW, Chen S, Kopp RP, Pavalko FM, Yu J and Bidwell JP: HMGB1 expression and release by bone cells. J Cell Physiol. 207:480–490. 2006. View Article : Google Scholar : PubMed/NCBI
4	Granero-Moltó F, Weis JA, Miga MI, Landis B, Myers TJ, O'Rear L, Longobardi L, Jansen ED, Mortlock DP and Spagnoli A: Regenerative effects of transplanted mesenchymal stem cells in fracture healing. Stem Cells. 27:1887–1898. 2009. View Article : Google Scholar : PubMed/NCBI
5	Glass GE, Chan JK, Freidin A, Feldmann M, Horwood NJ and Nanchahal J: TNF-alpha promotes fracture repair by augmenting the recruitment and differentiation of muscle-derived stromal cells. Proc Natl Acad Sci USA. 108:1585–1590. 2011. View Article : Google Scholar : PubMed/NCBI
6	Marsell R and Einhorn TA: The biology of fracture healing. Injury. 42:551–555. 2011. View Article : Google Scholar : PubMed/NCBI
7	Sidney LE, Kirkham GR and Buttery LD: Comparison of osteogenic differentiation of embryonic stem cells and primary osteoblasts revealed by responses to IL-1β, TNF-α and IFN-γ. Stem Cells Dev. 23:605–617. 2014. View Article : Google Scholar
8	Tso GH, Law HK, Tu W, Chan GC and Lau YL: Phagocytosis of apoptotic cells modulates mesenchymal stem cells osteogenic differentiation to enhance IL-17 and RANKL expression on CD4+ T cells. Stem Cells. 28:939–954. 2010.PubMed/NCBI
9	Guo J, Jie W, Shen Z, Li M, Lan Y, Kong Y, Guo S, Li T and Zheng S: SCF increases cardiac stem cell migration through PI3K/AKT and MMP-2/-9 signaling. Int J Mol Med. 34:112–118. 2014.PubMed/NCBI
10	Mingari MC, Moretta A and Moretta L: Regulation of KIR expression in human T cells: A safety mechanism that may impair protective T-cell responses. Immunol Today. 19:153–157. 1998. View Article : Google Scholar : PubMed/NCBI
11	Raaijmakers JH and Bos JL: Specificity in Ras and Rap signaling. J Biol Chem. 284:10995–10999. 2009. View Article : Google Scholar :
12	Katagiri K, Maeda A, Shimonaka M and Kinashi T: RAPL, a Rap1-binding molecule that mediates Rap1-induced adhesion through spatial regulation of LFA-1. Nat Immunol. 4:741–748. 2003. View Article : Google Scholar : PubMed/NCBI
13	Rebstein PJ, Cardelli J, Weeks G and Spiegelman GB: Mutational analysis of the role of Rap1 in regulating cytoskeletal function in Dictyostelium. Exp Cell Res. 231:276–283. 1997. View Article : Google Scholar : PubMed/NCBI
14	Bos JL, Franke B, M'Rabet L, Reedquist K and Zwartkruis F: In search of a function for the Ras-like GTPase Rap1. FEBS Lett. 410:59–62. 1997. View Article : Google Scholar : PubMed/NCBI
15	McLeod SJ and Gold MR: Activation and function of the Rap1 GTPase in B lymphocytes. Int Rev Immunol. 20:763–789. 2001. View Article : Google Scholar
16	Katagiri K, Ohnishi N, Kabashima K, Iyoda T, Takeda N, Shinkai Y, Inaba K and Kinashi T: Crucial functions of the Rap1 effector molecule RAPL in lymphocyte and dendritic cell trafficking. Nat Immunol. 5:1045–1051. 2004. View Article : Google Scholar : PubMed/NCBI
17	Creasy CL and Chernoff J: Cloning and characterization of a member of the MST subfamily of Ste20-like kinases. Gene. 167:303–306. 1995. View Article : Google Scholar : PubMed/NCBI
18	Chen CP, Huang JP, Chu TY, Aplin JD, Chen CY and Wu YH: Human placental multipotent mesenchymal stromal cells modulate trophoblast migration via Rap1 activation. Placenta. 34:913–923. 2013. View Article : Google Scholar : PubMed/NCBI
19	Peng S, Zhou G, Luk KD, Cheung KM, Li Z, Lam WM, Zhou Z and Lu WW: Strontium promotes osteogenic differentiation of mesenchymal stem cells through the Ras/MAPK signaling pathway. Cell Physiol Biochem. 23:165–174. 2009. View Article : Google Scholar : PubMed/NCBI
20	Mauri DN, Ebner R, Montgomery RI, Kochel KD, Cheung TC, Yu GL, Ruben S, Murphy M, Eisenberg RJ, Cohen GH, et al: LIGHT, a new member of the TNF superfamily and lymphotoxin alpha are ligands for herpesvirus entry mediator. Immunity. 8:21–30. 1998. View Article : Google Scholar : PubMed/NCBI
21	Hsu TL, Chang YC, Chen SJ, Liu YJ, Chiu AW, Chio CC, Chen L and Hsieh SL: Modulation of dendritic cell differentiation and maturation by decoy receptor 3. J Immunol. 168:4846–4853. 2002. View Article : Google Scholar : PubMed/NCBI
22	Sugiyama T, Suzuki H and Takahashi T: Light-induced rapid Ca²⁺ response and MAPK phosphorylation in the cells heterologously expressing human OPN5. Sci Rep. 4:53522014.
23	Yu KY, Kwon B, Ni J, Zhai Y, Ebner R and Kwon BS: A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis. J Biol Chem. 274:13733–13736. 1999. View Article : Google Scholar : PubMed/NCBI
24	Kuai J, Nickbarg E, Wooters J, Qiu Y, Wang J and Lin LL: Endogenous association of TRAF2, TRAF3, cIAP1 and Smac with lymphotoxin beta receptor reveals a novel mechanism of apoptosis. J Biol Chem. 278:14363–14369. 2003. View Article : Google Scholar : PubMed/NCBI
25	Irving SG, Zipfel PF, Balke J, McBride OW, Morton CC, Burd PR, Siebenlist U and Kelly K: Two inflammatory mediator cytokine genes are closely linked and variably amplified on chromosome 17q. Nucleic Acids Res. 18:3261–3270. 1990. View Article : Google Scholar : PubMed/NCBI
26	Bystry RS, Aluvihare V, Welch KA, Kallikourdis M and Betz AG: B cells and professional APCs recruit regulatory T cells via CCL4. Nat Immunol. 2:1126–1132. 2001. View Article : Google Scholar : PubMed/NCBI
27	Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC and Lusso P: Identification of RANTES, MIP-1 alpha and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science. 270:1811–1815. 1995. View Article : Google Scholar : PubMed/NCBI
28	Garcia-Zepeda EA, Combadiere C, Rothenberg ME, Sarafi MN, Lavigne F, Hamid Q, Murphy PM and Luster AD: Human monocyte chemoattractant protein (MCP)-4 is a novel CC chemokine with activities on monocytes, eosinophils and basophils induced in allergic and nonallergic inflammation that signals through the CC chemokine receptors (CCR)-2 and -3. J Immunol. 157:5613–5626. 1996.PubMed/NCBI
29	Naruse K, Ueno M, Satoh T, Nomiyama H, Tei H, Takeda M, Ledbetter DH, Coillie EV, Opdenakker G, Gunge N, et al: A YAC contig of the human CC chemokine genes clustered on chromosome 17q11.2. Genomics. 34:236–240. 1996. View Article : Google Scholar : PubMed/NCBI
30	Blanpain C, Migeotte I, Lee B, Vakili J, Doranz BJ, Govaerts C, Vassart G, Doms RW and Parmentier M: CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist. Blood. 94:1899–1905. 1999.PubMed/NCBI
31	Lamkhioued B, Garcia-Zepeda EA, Abi-Younes S, Nakamura H, Jedrzkiewicz S, Wagner L, Renzi PM, Allakhverdi Z, Lilly C, Hamid Q and Luster AD: Monocyte chemoattractant protein (MCP)-4 expression in the airways of patients with asthma. Induction in epithelial cells and mononuclear cells by proinflammatory cytokines. Am J Respir Crit Care Med. 162:723–732. 2000. View Article : Google Scholar : PubMed/NCBI
32	Lejmi E, Perriraz N, Clément S, Morel P, Baertschiger R, Christofilopoulos P, Meier R, Bosco D, Bühler LH and Gonelle-Gispert C: Inflammatory chemokines MIP-1δ and MIP-3α are involved in the migration of multipotent mesenchymal stromal cells induced by hepatoma cells. Stem Cells Dev. 24:1223–1235. 2015. View Article : Google Scholar : PubMed/NCBI
33	Zhang F, Wang C, Wang H, Lu M, Li Y, Feng H, Lin J, Yuan Z and Wang X: Ox-LDL promotes migration and adhesion of bone marrow-derived mesenchymal stem cells via regulation of MCP-1 expression. Mediators Inflamm. 2013:6910232013. View Article : Google Scholar : PubMed/NCBI
34	Burbach BJ, Medeiros RB, Mueller KL and Shimizu Y: T-cell receptor signaling to integrins. Immunol Rev. 218:65–81. 2007. View Article : Google Scholar : PubMed/NCBI